Posted inPharmaceutical
Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show
The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Posted inPharmaceutical
Laurus Labs Q2 Results: The Peptide and Oligonucleotide Capabilities Behind the CDMO Surge
The Laurus Labs Q2 results point to CDMO growth and new peptide capacity. What the science involves and what is not yet shown.
Posted inPharmaceutical
BPaL TB Regimen Patent India: What the Evidence and the Ruling Mean for Drug-Resistant TB
The BPaL TB regimen patent India ruling concerns novelty, not efficacy. How earlier studies figure in the dispute and what is unknown.
Posted inPharmaceutical
Eli Lilly Q3 2026 Results: The Pipeline and Approvals Behind the Sales Surge
The Eli Lilly Q3 2026 results by pipeline: approvals, oral and weekly options, retatrutide and which medicines remain investigational.
Posted inPharmaceutical
FDA ICH M15 Guidance: How Model-Informed Drug Development Is Evaluated
The FDA ICH M15 guidance frames how models support drug development. What MIDD is, why harmonisation matters and what the webinar covered.
Posted inPharmaceutical
Biogen Q3 2026 Results: Which Medicines Drove Growth and What the Pipeline Holds
The Biogen Q3 2026 results by product: growth drivers, the declining MS franchise and the Phase 3 readouts that could matter next.
Posted inPharmaceutical
India Cancer Medicine Price Revision 2026: What Patients Should Check From November 9
A guide to the India cancer medicine price revision 2026: how the NPPA list works, how to check your medicine, and what is still unclear.
Posted inPharmaceutical
Mylan Telmisartan Amlodipine Recall: What a Class III Drug Recall Means
What the Mylan telmisartan amlodipine recall means: Class III, superpotent tablets, five lots, and how to read an FDA recall notice.
Posted inPharmaceutical
SCHOTT Pharma India Name Change: Glass Syringes and Injectable Packaging in Focus
The SCHOTT Pharma India name change puts glass pre-fillable syringes and injectable packaging in focus. What the company makes and what is undisclosed.
Posted inPharmaceutical
Indoco Remedies AnaCipher ANVISA Approval: Why Bioequivalence Sites Are Inspected
What the Indoco Remedies AnaCipher ANVISA approval means for bioequivalence studies, and why regulators inspect clinical and bioanalytical sites.